Beclomethasone Dipropionate in Participants At Least 12 Years Old With Persistent Asthma
- Study Title
- A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
- Teva Identifier
- BDB-AS-301 | 2013-003397-27
- ClinicalTrials.gov Identifier
- NCT02031640
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Beclomethasone dipropionate | Drug: Placebo | Drug: Albuterol/salbutamol
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 12 Years and older
- Trial Duration
- 12/01/2013 - 12/01/2014
- Phase
- Phase 3
